Why Smart Patients Compare 1.7mg Wegovy to Mounjaro Pricing
Understanding 1.7mg Wegovy to Mounjaro Price Differences in the UK
When comparing 1.7mg Wegovy to Mounjaro, pricing transparency becomes crucial for long-term treatment planning. The 1.7mg dose represents weeks 13-16 of your Wegovy journey, positioning you just one step away from the 2.4mg maintenance dose. At this advanced stage, many patients evaluate whether continuing with Wegovy or switching to Mounjaro offers better value for sustained weight management. EverydayMeds provides competitive pricing on both treatments, ensuring you're never forced to compromise on your preferred medication due to cost barriers.
Our 1.7mg Wegovy to Mounjaro comparison reveals distinct value propositions for each treatment. Wegovy 1.7mg costs £139.99 as a single pen, whilst our Elevate Duo bundle (1.7mg + 2.4mg) at £369.99 provides seamless transition to maintenance dosing. Mounjaro follows a different pricing structure reflecting its dual-hormone mechanism, and both treatments include comprehensive clinical assessment, prescriber review, and next-day delivery. This transparent approach helps you make informed decisions without hidden costs affecting your treatment continuity.
Complete Wegovy 1.7mg Pricing and Bundle Options
EverydayMeds offers the UK's most competitive Wegovy 1.7mg pricing with multiple purchase options to suit your treatment schedule. Single pens cost £139.99, whilst our Consistency 1.7mg bundle (two pens) provides extended supply at £309.99 for patients requiring additional weeks at this dose. New customers apply code FIRST40 at checkout to access these prices, whilst returning customers use DOSE25 for continued savings. All prices include clinical assessment, prescriber review, and temperature-controlled next-day delivery from our GPhC-registered pharmacy (#9012878).
Our innovative bundle system recognises that 1.7mg Wegovy to Mounjaro comparisons often occur when patients are planning their transition to maintenance dosing. The Elevate Trio bundle (1mg, 1.7mg, 2.4mg) at £499.99 provides complete dose escalation through to maintenance, whilst individual dosing allows flexibility for patients considering switching to Mounjaro. Both approaches ensure uninterrupted treatment whilst you evaluate which prescription-only medicine best supports your long-term weight management goals alongside a reduced-calorie diet and increased physical activity.
Clinical Evidence Supporting 1.7mg Wegovy to Mounjaro Decisions
Clinical trials demonstrate both Wegovy and Mounjaro's effectiveness, though direct head-to-head comparisons remain limited due to different trial designs and patient populations. The STEP programme, including findings published by Wilding et al. in NEJM 2021, showed patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes. At the 1.7mg dose, patients typically experience substantial appetite reduction and enhanced satiety, positioning them well for maintenance phase success.
Mounjaro's SURMOUNT trials demonstrate the potential benefits of dual GIP/GLP-1 receptor activation, offering a different mechanistic approach to weight management. When comparing 1.7mg Wegovy to Mounjaro, your prescriber considers factors including your response to GLP-1 therapy, tolerability profile, and treatment goals. Both medications require ongoing commitment and work most effectively when combined with sustained lifestyle modifications.
How Wegovy 1.7mg Works in Your Weight Management Journey
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to regulate appetite and food intake. At the 1.7mg dose, administered once weekly via the convenient FlexTouch pen, semaglutide significantly reduces appetite whilst promoting feelings of fullness after smaller meals. This mechanism helps patients naturally reduce caloric intake without the constant hunger that often undermines weight management efforts. The medication works on brain appetite centres, potentially reducing food cravings and supporting sustained dietary changes. Unlike some weight management approaches, Wegovy's hormonal mechanism aligns with your body's natural satiety signals.
Simple Ordering Process for 1.7mg Wegovy or Mounjaro
EverydayMeds streamlines access to both Wegovy 1.7mg and Mounjaro through our comprehensive online service designed for busy patients requiring prescription-only medicines. The process begins with a detailed 3-minute clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review every application within 3 working days (or 24 hours with express service), ensuring appropriate prescribing and identifying any contraindications. Once approved, your medication ships via next-day delivery using specialized cold-chain logistics to maintain temperature integrity throughout transport. All patients receive detailed administration guidance and ongoing support from our clinical team.
Storage Advantages When Comparing 1.7mg Wegovy to Mounjaro
Practical considerations often influence treatment choices, with storage requirements representing a key differentiator when comparing 1.7mg Wegovy to Mounjaro options. Wegovy pens remain stable for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for frequent travellers or patients with unpredictable schedules. Both medications require refrigeration at 2-8°C before first use, and the FlexTouch pen system ensures accurate dosing with minimal preparation. The 1.7mg dose continues the once-weekly injection schedule, maintaining treatment convenience as you approach maintenance phase dosing.
Long-term Value Planning for 1.7mg Wegovy to Mounjaro Treatment
Experienced patients comparing 1.7mg Wegovy to Mounjaro often focus on long-term value rather than short-term savings, recognising weight management as an ongoing commitment requiring sustained medication access. At this advanced dosing stage, treatment response patterns become clearer, helping predict maintenance phase requirements and total treatment costs. EverydayMeds supports this planning approach through flexible purchasing options and consistent pricing for returning customers using code DOSE25.
The transition from 1.7mg to 2.4mg maintenance represents a significant milestone where many patients finalise their treatment choice between Wegovy and Mounjaro. Our clinical team provides ongoing support during this decision-making process, ensuring continuity regardless of which prescription-only medicine best serves your individual needs. Both treatments require long-term commitment for sustained results, making reliable supply and competitive pricing essential for treatment success.
Start Your Treatment Comparison Today
Ready to compare 1.7mg Wegovy to Mounjaro with the UK's most transparent pricing? EverydayMeds eliminates the guesswork with clear costs, comprehensive clinical support, and flexible purchasing options for both treatments. New customers use code FIRST40 at checkout, whilst returning customers benefit from DOSE25 for continued savings. Visit https://everydaymeds.co.uk/products/wegovy-1-7mg to begin your clinical assessment or explore Mounjaro options through our comparison service. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine medication with expert oversight, supporting your weight management journey with the treatment that best matches your individual needs and budget.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
